Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Ciena (CIEN) -- Ignore unavailable to you. Want to Upgrade?

To: Raymond Duray who wrote (9728)	10/26/2000 4:55:08 AM
From: Walkingshadow	Respond to of 12623

Ray, << I non-concur. The play of the decade is proteomics. >> I see your non-concur, and I raise you another non-concur. Not so much proteomics per se, but the huge global markets that will be created de novo once proteomics really comes into its own. "Created" is probably a bad choice of words. Thermonuclear detonation is probably more like it. It will be the single most important enabling breakthrough in biotech ever, IMHO, although I realize it is fundamentally dependent on genomics. But, genomics is all but a done deal, in that it is only a matter of time, sequencing muscle, and supercomputing force now. The effect on medicine will be analgous to the effect that the transition from hunter/wanderers to stable, agrarian lifestyles had on the development of civilization. WS

To: Raymond Duray who wrote (9728)	10/26/2000 8:47:23 AM
From: John F. Dowd	Read Replies (1) \| Respond to of 12623

Raymond: Excuse the ignorance but what is proteomics and where can one read up on it and what company's are in the van of its development? Thanks. JFD